PDLIM7 and B-cell non-Hodgkin lymphoma: Our study identifies PIKfyve as a critical regulator of OBI‐induced LMP and DCD, providing mechanistic insights into how lysosomal integrity governs B‐cell lymphoma sensitivity to anti‐CD20 therapy.